Wiley

Therapeutic Apheresis Template

Write in a clean editor, then format for Therapeutic Apheresis in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Therapeutic Apheresis format

Therapeutic Apheresis is a peer-reviewed journal published by Wiley, covering Complement system in diseases, Peripheral Neuropathies and Disorders, Platelet Disorders and Treatments.

PublisherWiley
Reference styleAuthor–year (Chicago)
Author–year — (Smith, 2023) in the text
Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Therapeutic Apheresis 12 (3): 45–58.

Formats any DOI in Therapeutic Apheresis style. No sign-up.

Publishes research inComplement system in diseases Peripheral Neuropathies and Disorders Platelet Disorders and Treatments Systemic Lupus Erythematosus Research Lipoproteins and Cardiovascular Health
ISSN1091-6660
h-index43
i10-index245
Total citations7,909
Top institutions publishing hereBaylor College of Medicine
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Therapeutic Apheresis per year

87
1997
74
1998
67
1999
91
2000
103
2001
100
2002
1
2003
1
2010

Citation impact of Therapeutic Apheresis by publication year

948
1997
1.1K
1998
927
1999
1.1K
2000
1.6K
2001
2.1K
2002
0
2003
1
2010

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Therapeutic Apheresis

Extracorporeal Photochemotherapy for the Treatment of Graft‐Versus‐Host Disease

Roberto Dall’Amico, Chiara Messina · 1 Aug 2002

Photopheresis (extracorporeal photochemotherapy, ECP) is a new type of photochemotherapy used for the treatment of oncological and autoimmune diseases. Additionally, recent reports indicate that this therapy is promising in both pediatric and adult patients who develop graft versus host disease (GVHD) resistant to conventional protocols after bone marrow transplantation (BMT). In this paper, we review…

Leukocytoreduction for Acute Leukemia

Pierluigi Porcu, Sherif F. Farag, Guido Marcucci et al. · 1 Feb 2002

Both in children and adults, acute leukemia may present with extremely high blast counts; a phenomenon known as hyperleukocytosis. Respiratory failure, intracranial bleeding, and severe metabolic abnormalities frequently occur in acute hyperleukocytic leukemias (AHLs) and are the primary determinants of the high early mortality (20% to 40%) observed. The process leading to these complications has…

Extracorporeal Endotoxin Removal by Polymyxin B Immobilized Fiber Cartridge: Designing and Antiendotoxin Efficacy in the Clinical Application

Hisataka Shoji, Tohru Tani, Kazuyoshi Hanasawa et al. · 1 Feb 1998

We have developed an extracorporeal hemoadsorption cartridge, the PMX cartridge, to eliminate endotoxin from peripheral blood circulation. As an adsorbent, a polymyxin B covalently immobilized fiber (PMX-F) was developed. After the optimization of the condition of immobilization, fixed polymyxin B maintained its ability to adsorb endotoxin and its bactericidal activity. PMX-F could detoxify many kinds…

Improvement of Multiple Organ Functions in Hepatorenal Syndrome During Albumin Dialysis with the Molecular Adsorbent Recirculating System

Steffen Mitzner, Sebastian Klammt, P Peszynski et al. · 1 Oct 2001

Recently, significant improvement of renal function and prolongation of survival were reported in hepatorenal syndrome (HRS) patients treated with the Molecular Adsorbent Recirculating System (MARS). As no impact on extrarenal organ function was documented, this trial looked into multiple organ function changes during MARS in HRS patients. Eight HRS patients (4 male, mean age 42.1…

A Role for Granulocyte and Monocyte Apheresis in the Treatment of Rheumatoid Arthritis

Nobuhito Kashiwagi, Ichirou Hirata, Reiji Kasukawa · 1 May 1998

Rheumatoid arthritis (RA) is an inflammatory condition, the etiology of which is not well understood. Recent reports indicate a major role of granulocytes in the pathogenesis of RA; arthritic joints are infiltrated with phagocytic leukocytes, granulocytes, and monocytes/macrophages, and it is believed that these cells, by releasing degradative proteinases, cytokines, and reactive oxygen species, contribute…

Therapeutic Apheresis template — frequently asked questions

How do I write a paper in the Therapeutic Apheresis format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Therapeutic Apheresis template. When you export, DocuGuru compiles the paper into the official Wiley format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Therapeutic Apheresis use?
Therapeutic Apheresis uses Author–year (Chicago) references, shown as author–year markers such as (Smith, 2023) in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Therapeutic Apheresis 12 (3): 45–58.
Do I need to know LaTeX to submit to Therapeutic Apheresis?
No. DocuGuru generates the USG LaTeX class and compiles the PDF for you in the background, so you get a Wiley-ready Therapeutic Apheresis document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Therapeutic Apheresis template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Therapeutic Apheresis format with correct headings, figures, tables, and author–year citations.
Who publishes Therapeutic Apheresis?
Therapeutic Apheresis is a multidisciplinary journal published by Wiley. DocuGuru's Therapeutic Apheresis template matches Wiley's official submission format.
Can I export a submission-ready Therapeutic Apheresis PDF?
Yes — DocuGuru produces a PDF built with the official Therapeutic Apheresis template (the USG class) that is ready to submit to Wiley, together with the matching LaTeX source files.
How much does the Therapeutic Apheresis template cost?
You can start writing in the Therapeutic Apheresis template for free. Exporting the final submission-ready Therapeutic Apheresis PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Therapeutic Apheresis template